NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 101 filers reported holding NATERA INC in Q2 2016. The put-call ratio across all filers is 5.75 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $439 | -99.9% | 9,930 | -23.0% | 0.04% | -21.4% |
| Q3 2022 | $565,000 | -80.2% | 12,900 | -48.6% | 0.06% | -80.5% |
| Q2 2021 | $2,852,000 | +764.2% | 25,120 | +657.1% | 0.29% | +441.5% |
| Q4 2020 | $330,000 | -67.8% | 3,318 | -76.6% | 0.05% | -67.9% |
| Q3 2020 | $1,026,000 | +27.5% | 14,207 | -12.0% | 0.16% | +36.4% |
| Q2 2020 | $805,000 | -21.3% | 16,138 | -52.9% | 0.12% | -39.5% |
| Q1 2020 | $1,023,000 | +106.7% | 34,259 | +133.0% | 0.20% | +153.2% |
| Q4 2019 | $495,000 | +78.7% | 14,701 | +46.5% | 0.08% | +68.1% |
| Q2 2019 | $277,000 | -14.0% | 10,035 | -25.3% | 0.05% | +4.4% |
| Q3 2018 | $322,000 | +86.1% | 13,430 | -6.1% | 0.04% | -4.3% |
| Q2 2016 | $173,000 | -44.2% | 14,309 | -49.9% | 0.05% | -55.2% |
| Q3 2015 | $310,000 | – | 28,543 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |